CTRI Number |
CTRI/2018/01/011632 [Registered on: 31/01/2018] Trial Registered Prospectively |
Last Modified On: |
12/04/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Observational |
Type of Study
|
Cross Sectional Study |
Study Design |
Other |
Public Title of Study
|
Whether Anti-diabetic drugs can be used with Ayurvedic herbs? |
Scientific Title of Study
|
Pharmacoepidemiological survey to observe the pattern of use
Of Classical Ayurvedic herbs used along with Conventional Anti-diabetic medicines in Type II Diabetes Mellitus and Pre-clinical study for
Herb-Drug Interactions of topmost unexplored plant |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Prof Tanuja Nesari |
Designation |
Head |
Affiliation |
All india Institute of Ayurveda |
Address |
Room No 218, Second Floor, Dept of Dravyaguna, All India Institute of Ayurveda
Gautam Puri, Sarita Vihar
New Delhi DELHI 110076 India |
Phone |
9958817145 |
Fax |
|
Email |
tnesari@hotmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Prof Tanuja Nesari |
Designation |
Head |
Affiliation |
All india Institute of Ayurveda |
Address |
Room No 218, Second Floor, Dept of Dravyaguna, All India Institute of Ayurveda
Gautam Puri, Sarita Vihar
New Delhi DELHI 110076 India |
Phone |
9958817145 |
Fax |
|
Email |
tnesari@hotmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Geetika Pahuja |
Designation |
PG Scholar |
Affiliation |
All India Institute of Ayurveda |
Address |
Dept of Dravyaguna, All India Institute of Ayurveda
Gautam Puri, Sarita Vihar
New Delhi DELHI 110076 India |
Phone |
8750737430 |
Fax |
|
Email |
pahujagtk@gmail.com |
|
Source of Monetary or Material Support
|
All India Institute of Ayurveda, Gautam Puri, Sarita Vihar, New Delhi |
|
Primary Sponsor
|
Name |
All India Institute of Ayurveda |
Address |
Gautam Puri, Sarita Vihar, New Delhi |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Geetika Pahuja |
All India Institute of Ayurveda |
Room no. 219, second floor, department of dravyaguna, All India Institute of Ayurveda,Gautam Puri, Sarita Vihar New Delhi DELHI |
8750737430
Pahujagtk@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
Herb-Drug Interactions with Pattern of use of Classical Ayurvedic Herbs along with conventional Anti-diabetic medicines by the individuals whose blood glucose levels are elevated., (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
30.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Known Type II Diabetic patients taking Classical Ayurvedic Herbs along with Conventional Anti-Diabetic Medicines atleast from last six months |
|
ExclusionCriteria |
Details |
1) Type I Diabetic patients.
2) Type II Diabetic patients who are on Insulin.
3) Diabetic patients suffering with associated diseases like Asthma, Cardiac disorders etc. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Glycemic control based on FBS, PPBS and HbA1C |
12 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
Clinical endpoints – Relief or aggression of Signs and symptoms
|
12 months |
Quality of life
(The Quality of Life is proposed to be evaluated with the help of WHOQOL-SF 36 scale) |
12 months |
|
Target Sample Size
|
Total Sample Size="400" Sample Size from India="400"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="250" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
15/02/2018 |
Date of Study Completion (India) |
30/11/2018 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
Modification(s)
|
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. As per WHO, the global prevalence (age standardized) of diabetes has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population as per the 2014 data and India had 69.2 million people living with diabetes i.e. 8.7% as per the 2015 data and among these 90% of cases comprises Type II Diabetes. WHO also projects that diabetes will be the 7th leading cause of death in 2030. As the Prevalence of Diabetes has been rising rapidly in middle and low- income countries, it is now an important public health problem, one of four priority non-communicable diseases (NCDs) targeted for action by world leaders. According to International Diabetes Federation(IDF) India is the home to the second largest number of adults living with diabetes worldwide, after china and it’s a high alert time for all the medical fraternity to find out prophylaxis and preventive measures to control and manage diabetes and its complications. In Ayurveda, Diabetes Mellitus can be co-related with Madhumeha mentioned under the umbrella of Prameha. As prevention and prophylaxis is the eternal strength of Ayurveda, there are approximately 67 herbs mentioned in Samhitas which have beneficial effects in Madhumeha~ Diabetes Mellitus. Since Diabetes is a chronic disease and Ayurveda also considers it as Asadhya Vyadhi, medicines are to be taken for longer duration, hence it has been observed that majority of people concurrently use one or the other herbs as per their conditions either by their own choice or after being advised by the physicians alone or along with other conventional antidiabetic medicines. Due to increasing resistance of conventional medicines the world is moving from the “synthetic world towards a more organic worldâ€, patients are increasingly seeking herbal remedies to manage medical conditions, complement conventional therapies, maintain their overall health and well-being. As per a study, 80% of the world’s population living in the developing world relies on herbal medicinal products as a primary source of healthcare and traditional medical practice which involves the use of herbs in those communities. As there is a well-accepted general belief by the public that herbal medicines are safe because they are natural, but herbal medicines contain a combination of pharmacologically active plant constituents that are claimed to work synergistically to produce significant effects and may interact with other conventional medicines if taken simultaneously and their actions may alter and sometimes the herbs may possess interactions. Hence, herbs though a great boon for mankind, may become curse if used injudiciously. However, there are many questions paused regarding their dosage forms, dose, delivery regimen, time of administration, time gap between conventional and AYUSH medicines and herb to drug interactions if taken in combination with conventional Medicines. To get a deep and clear vision about the patient’s condition, Vaagbhatta has mentioned three Pariksha: Darshana, Sparshana and Prashna Pariksha. Through these three Pariksha, a better understanding and analysis of disease and diseased person can be made and the big umbrella of Prashana Pariksha covers the Pharmaco-epidemiological study of the present Scenario. Pharmaco-epidemiology is the study of the use and the effects of drugs in large numbers of people and Ayurvedic Pharmacoepidemiology essentially makes an assessment for the field reality and the community practice of Ayurvedatherapeutics. In this modern era, collecting the Pharmacoepidemiological data is considered to be the Level I evidence as it provides the scientific data along with the experiential proof of evidence. So, this kind of Observational study is the need of hour. Though some studies have already been taken on Herb-Drug interactions however the scientifically validated epidemiological data still awaits. But till date no clinical experience based data regarding actual database of use of Ayurvedic drugs mentioned in Diabetes Mellitus type II or their interactions i.e., synergistic effects or adverse effects is available. Hence, keeping the need of hour in mind, a Pharmacoepidemiological study is planned to provide the significant database for pattern of use of herbs which are used in combination with Oral Hypoglycemic agents along with the proof of evidence. Therefore, an effort will be made to review the pharmacoepidemiological profile of the unexplored Classical Ayurvedic Herbs interaction with Oral Hypoglycemic agents when given in combination for management of Diabetes Mellitus Type II in Pre-clinical studies. |